Chandriah, Haarathi (2025) Development Of Multi-Criteria Decision Analysis (Mcda) Framework For Formulary Listing Decisions Of Oncology Drugs In Malaysia. PhD thesis, Perpustakaan Hamzah Sendut.
![[img]](http://eprints.usm.my/style/images/fileicons/application_pdf.png) |
PDF
Download (555kB) |
Abstract
Given the increasing incidence of cancer in the country and the introduction of new high-cost innovative medicines, ensuring access to cancer drugs remains a significant public health challenge. National formulary listing and drug pricing play crucial roles in ensuring access to these drugs. The current issues surrounding cancer drug prices and access in the country are not known. Moreover, the existing health technology assessment (hta) approach for value assessment of cancer drugs for formulary listing is considered to be lacking in comprehensiveness as it does not fully capture other dimensions of value such as disease severity. Therefore, this thesis aims to develop a multi criteria decision analysis (mcda) framework for value assessment of cancer drugs while concurrently investigating other issues related to access to cancer drugs. Documents review and secondary data analysis using formulary listing data from year 2011 to 2018 was conducted to identify challenges related to cancer drug access. In developing the mcda framework, a cross-sectional survey involving multiple stakeholders was conducted to determine preferences for formulary decision criteria.
| Item Type: | Thesis (PhD) |
|---|---|
| Subjects: | R Medicine > RS Pharmacy and materia medica > RS1-441 Pharmacy and materia medica |
| Divisions: | Pusat Pengajian Sains Farmasi (School of Pharmacy) > Thesis |
| Depositing User: | Mr Hasmizar Mansor |
| Date Deposited: | 11 May 2026 02:03 |
| Last Modified: | 11 May 2026 02:03 |
| URI: | http://eprints.usm.my/id/eprint/64136 |
Actions (login required)
 |
View Item |
